Investigating Alternative Nuclear Reactions for Medical Isotope Production
Investigating Alternative Nuclear Reactions for Medical Isotope Production
批准号:
10155519
负责人:
Jennifer Anne Shusterman
金额:
$15.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-06-01 至 2021-08-02
关键词:
ClinicalCommunitiesCommunity MedicineComplementCyclotronsDevelopmentDiagnosticDiscipline of Nuclear MedicineFutureGeometryHeavy IonsHeliumIsotopesLaboratory StudyLinear Accelerator Radiotherapy SystemsMalignant NeoplasmsMeasurementMeasuresMedicalMedicineMethodsNeutronsNuclearNuclear ReactorsParentsPathway interactionsPatientsPotassiumProbabilityProductionProtonsRadioactiveRadiochemistryRadioisotopesReactionResearchRouteSodium ChlorideTechniquesTherapeuticThickTranslatingTranslational ResearchWorkaccelerator mass spectrometryclinical applicationdeuteroninterestirradiationlaboratory developmentparticle beampreventradiochemicalresearch study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Investigating Alternative Nuclear Reactions for Medical Isotope Production
ABSTRACT
The array of radionuclides used for, or considered as good candidates for, nuclear medicine has expanded in
recent years. Of these radionuclides 44Sc and 67Cu have shown great promise for use in diagnostic and
therapeutic applications, respectively. A challenge associated with translating 44Sc and 67Cu from research scale
to long-term medical use is the difficulty in producing each of these radionuclides in large quantities. The
production limitation is due to the low cross sections (the probability) of the nuclear reactions that create the
purist supply of these isotopes. Since production routes using particle beams commonly used for medical
isotopes (protons, neutrons, deuterons) do not result in sufficient cross sections, the proposed work aims to
investigate employing heavy ion beam reactions. Heavy ion beams, such as 7Li, offer the potential to produce
67Cu and 44Ti (44Ti is the 44Sc parent) at higher cross sections. The proposed research will focus on the
measurement of the cross sections for such reactions. Additionally, post irradiation radiochemistry will be
performed so that the final purity of the radionuclides can be compared to the current production methods.
Successful demonstration of higher production rates with comparable radionuclide purity will offer an
additional production route to make these valuable medical isotopes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金